Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Long-Term Debt Repayments (2021)

Vivos Therapeutics (VVOS) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $25000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $25000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was $25000.0, a N/A change, with the full-year FY2021 number at $25000.0, down 66.67% from a year prior.
  • Long-Term Debt Repayments was $25000.0 for Q1 2021 at Vivos Therapeutics.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $25000.0 in Q1 2021 to a low of $25000.0 in Q1 2021.